miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome

scientific article published on 3 April 2015

miR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/AJPHEART.00654.2014
P932PMC publication ID4451306
P698PubMed publication ID25840830
P5875ResearchGate publication ID274458979

P50authorSpencer ProctorQ47890729
Russell TerryQ60369691
P2093author name stringErika Smith
Petra Rocic
Rashmi Jadhav
Rebecca Hutcheson
Robert Barrington
Brenda Hutcheson
Jennifer Chaplin
P2860cites workMicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cellsQ21135545
Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endotheliumQ28219326
MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targetsQ28248253
Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndromeQ28389912
Coronary collateral growth--back to the futureQ28658320
Neutrophil cell surface receptors and their intracellular signal transduction pathways.Q30009577
Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implicationsQ30430026
miR-21 normalizes vascular smooth muscle proliferation and improves coronary collateral growth in metabolic syndromeQ34072676
Restoration of coronary endothelial function in obese Zucker rats by a low-carbohydrate dietQ34601284
Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosisQ34658879
MMPs 2 and 9 are essential for coronary collateral growth and are prominently regulated by p38 MAPK.Q35529307
Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndromeQ35767686
Silencing of microRNA families by seed-targeting tiny LNAsQ36522844
MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndromeQ36773823
Bcl-2 family members regulate anoxia-induced cell deathQ36879207
Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular diseaseQ36918536
Mechanisms of arteriogenesisQ37237370
Wall thickness of coronary vessels varies transmurally in the LV but not the RV: implications for local stress distributionQ37298352
Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic miceQ37406302
Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2.Q40179416
Analysis of the alpha4beta1 integrin-osteopontin interactionQ40868329
Altered PYK2 phosphorylation by ANG II in hypertensive vascular smooth muscleQ42515619
Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatinQ42571891
Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD.Q45866264
The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growthQ46930209
Fibrinolysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood.Q50903243
Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetesQ59279106
Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responsesQ59421710
Down-regulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin ii-induced signaling in vascular smooth muscleQ73656443
Cardiovascular disease in the JCR:LA-cp ratQ77582051
Acute phase response, inflammation and metabolic syndrome biomarkers of Libby asbestos exposureQ83514676
P433issue11
P921main subjectmetabolic syndromeQ657193
P304page(s)H1323-35
P577publication date2015-04-03
P1433published inAmerican Journal of Physiology Heart and Circulatory PhysiologyQ3193662
P1476titlemiR-21-mediated decreased neutrophil apoptosis is a determinant of impaired coronary collateral growth in metabolic syndrome
P478volume308

Reverse relations

cites work (P2860)
Q40608876Effects of ghrelin on the apoptosis of human neutrophils in vitro
Q51239324Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.
Q50081720Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation
Q90884479Identification of key protein-coding genes and lncRNAs in spontaneous neutrophil apoptosis
Q35904086Impaired coronary collateral growth: miR-shaken neutrophils caught in the act.
Q28066227Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain
Q37010626Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy
Q35973580Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells

Search more.